Bifogade filer
PDF
Kurs & Likviditet
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
AcouSort's technology makes it possible to fractionate the different cell types in a blood sample, isolate extracellular vesicles, or wash cells to remove contaminants, without having any physical contact with the sample. The technology continues to find its way into an increasing number of life science applications. On October 15-19, 2023, AcouSort will attend µTAS 2023, the 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences, to present the unique features of its technology.
- One poster is presented by Senior Scientist Mikael Evander and addresses the use of AcouTrap technology to isolate and wash stem cells before they are used in therapy
- The other poster is presented by AcouSort's NIH customer Dr Stephen Adler and addresses the use of the AcouWash technology for centrifuge-free radiolabeling ofimmune cells in cancer treatment
Both poster presentations are related to the use of AcouSort's technology in different cell therapy applications. In conjunction with the conference, AcouSort will also release a new application note on the new high-throughput acoustic separation solution for automated processing in cell therapy manufacturing.
"µTAS 2023 is a perfect conference for us to present our unique technology. Over the past year or so, we have made a significant number of inroads into the cell therapy space. Our ambition now is to establish as many research collaborations as possible to pave the way for future OEM partnerships," says Jessica Congiu, Commercial Product Manager at AcouSort.